Trial Outcomes & Findings for Nexplanon Application Post-Abortion (NAPA) (NCT NCT02037919)

NCT ID: NCT02037919

Last Updated: 2024-02-12

Results Overview

Current use of Etonogestrel implant, confirmed via phone by participant palpation, at 6 months post-insertion, with all entire sample used in calculations.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

148 participants

Primary outcome timeframe

6 months

Results posted on

2024-02-12

Participant Flow

A total of 148 participants were recruited and randomized into two study arms.

Participants were randomized.

Participant milestones

Participant milestones
Measure
Immediate Nexplanon Insertion
An etonogestrel rod will be placed within 15 minutes following the abortion procedure. Immediate Nexplanon Insertion: Patient will have a Nexplanon inserted within 15 minutes of her abortion
Post-op Nexplanon Insertion
Participants in the "delayed" placement group will be asked to return to Magee-Womens Hospital for a post-abortion visit 2-4 weeks following the procedure. Participants in the delayed group will be offered a method of contraception to use in the interim between their procedure and their insertion appointment. At this time an etonogestrel rod will be placed in her arm using standard procedure. Post-op Nexplanon Insertion: Place Nexplanon at post operative visit rather than at surgery
Overall Study
STARTED
73
75
Overall Study
Had Implant Inserted
73
32
Overall Study
Contacted at Six Months and Using Implant
40
19
Overall Study
Contacted at 6 Months and Not Using Implant
3
11
Overall Study
COMPLETED
43
30
Overall Study
NOT COMPLETED
30
45

Reasons for withdrawal

Reasons for withdrawal
Measure
Immediate Nexplanon Insertion
An etonogestrel rod will be placed within 15 minutes following the abortion procedure. Immediate Nexplanon Insertion: Patient will have a Nexplanon inserted within 15 minutes of her abortion
Post-op Nexplanon Insertion
Participants in the "delayed" placement group will be asked to return to Magee-Womens Hospital for a post-abortion visit 2-4 weeks following the procedure. Participants in the delayed group will be offered a method of contraception to use in the interim between their procedure and their insertion appointment. At this time an etonogestrel rod will be placed in her arm using standard procedure. Post-op Nexplanon Insertion: Place Nexplanon at post operative visit rather than at surgery
Overall Study
Lost to Follow-up
30
45

Baseline Characteristics

Nexplanon Application Post-Abortion (NAPA)

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Immediate Nexplanon Insertion
n=73 Participants
An etonogestrel rod will be placed within 15 minutes following the abortion procedure. Immediate Nexplanon Insertion: Patient will have a Nexplanon inserted within 15 minutes of her abortion
Post-op Nexplanon Insertion
n=75 Participants
Participants in the "delayed" placement group will be asked to return to Magee-Womens Hospital for a post-abortion visit 2-4 weeks following the procedure. Participants in the delayed group will be offered a method of contraception to use in the interim between their procedure and their insertion appointment. At this time an etonogestrel rod will be placed in her arm using standard procedure. Post-op Nexplanon Insertion: Place Nexplanon at post operative visit rather than at surgery
Total
n=148 Participants
Total of all reporting groups
Age, Continuous
25 years
n=99 Participants
23 years
n=107 Participants
24 years
n=206 Participants
Sex: Female, Male
Female
73 Participants
n=99 Participants
75 Participants
n=107 Participants
148 Participants
n=206 Participants
Sex: Female, Male
Male
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Race/Ethnicity, Customized
Race · White
28 Participants
n=99 Participants
22 Participants
n=107 Participants
50 Participants
n=206 Participants
Race/Ethnicity, Customized
Race · African American
45 Participants
n=99 Participants
52 Participants
n=107 Participants
97 Participants
n=206 Participants
Race/Ethnicity, Customized
Race · Native American or Alaska Native
0 Participants
n=99 Participants
1 Participants
n=107 Participants
1 Participants
n=206 Participants
Region of Enrollment
United States
73 Participants
n=99 Participants
75 Participants
n=107 Participants
148 Participants
n=206 Participants
Education
Less than high school
10 Participants
n=99 Participants
14 Participants
n=107 Participants
24 Participants
n=206 Participants
Education
High school equivalency certificate
27 Participants
n=99 Participants
25 Participants
n=107 Participants
52 Participants
n=206 Participants
Education
Some college
28 Participants
n=99 Participants
31 Participants
n=107 Participants
59 Participants
n=206 Participants
Education
Associate's degree
5 Participants
n=99 Participants
2 Participants
n=107 Participants
7 Participants
n=206 Participants
Education
Bachelor's degree
3 Participants
n=99 Participants
3 Participants
n=107 Participants
6 Participants
n=206 Participants
Marital Status
Never married
69 Participants
n=99 Participants
70 Participants
n=107 Participants
139 Participants
n=206 Participants
Marital Status
Married
2 Participants
n=99 Participants
2 Participants
n=107 Participants
4 Participants
n=206 Participants
Marital Status
Separated or divorced
2 Participants
n=99 Participants
3 Participants
n=107 Participants
5 Participants
n=206 Participants
Positive Smoking Status
17 Participants
n=99 Participants
15 Participants
n=107 Participants
32 Participants
n=206 Participants
Insurance Type
None
20 Participants
n=99 Participants
10 Participants
n=107 Participants
30 Participants
n=206 Participants
Insurance Type
Public
50 Participants
n=99 Participants
57 Participants
n=107 Participants
107 Participants
n=206 Participants
Insurance Type
Private
3 Participants
n=99 Participants
7 Participants
n=107 Participants
10 Participants
n=206 Participants
Insurance Type
Private and Public
0 Participants
n=99 Participants
1 Participants
n=107 Participants
1 Participants
n=206 Participants
Using insurance for D&E
Yes
1 Participants
n=99 Participants
3 Participants
n=107 Participants
4 Participants
n=206 Participants
Using insurance for D&E
No
20 Participants
n=99 Participants
11 Participants
n=107 Participants
31 Participants
n=206 Participants
Using insurance for D&E
Not Covered
52 Participants
n=99 Participants
61 Participants
n=107 Participants
113 Participants
n=206 Participants
Latina
22 Participants
n=99 Participants
20 Participants
n=107 Participants
42 Participants
n=206 Participants
Total no. of pregnancies
Total
4 Number of pregnancies
n=99 Participants
4 Number of pregnancies
n=107 Participants
4 Number of pregnancies
n=206 Participants
Total no. of pregnancies
Term
1 Number of pregnancies
n=99 Participants
1 Number of pregnancies
n=107 Participants
1 Number of pregnancies
n=206 Participants
Total no. of pregnancies
Preterm
0 Number of pregnancies
n=99 Participants
0 Number of pregnancies
n=107 Participants
0 Number of pregnancies
n=206 Participants
Total no. of pregnancies
Abortion
1 Number of pregnancies
n=99 Participants
1 Number of pregnancies
n=107 Participants
1 Number of pregnancies
n=206 Participants
No. of children alive
2 Number of children alive
n=99 Participants
1 Number of children alive
n=107 Participants
1.5 Number of children alive
n=206 Participants
Prior D&E
36 Participants
n=99 Participants
41 Participants
n=107 Participants
77 Participants
n=206 Participants
D&E indication
Social or economic
59 Participants
n=99 Participants
61 Participants
n=107 Participants
120 Participants
n=206 Participants
D&E indication
Fetal anomaly
0 Participants
n=99 Participants
2 Participants
n=107 Participants
2 Participants
n=206 Participants
D&E indication
Maternal health issue
2 Participants
n=99 Participants
4 Participants
n=107 Participants
6 Participants
n=206 Participants
D&E indication
Other
15 Participants
n=99 Participants
15 Participants
n=107 Participants
30 Participants
n=206 Participants
D&E indication
Declined to answer
2 Participants
n=99 Participants
2 Participants
n=107 Participants
4 Participants
n=206 Participants
Birth control methods used in the past
Implant
3 Participants
n=99 Participants
3 Participants
n=107 Participants
6 Participants
n=206 Participants
Birth control methods used in the past
LNG IUD
5 Participants
n=99 Participants
5 Participants
n=107 Participants
10 Participants
n=206 Participants
Birth control methods used in the past
Pill, patch, or ring
55 Participants
n=99 Participants
52 Participants
n=107 Participants
107 Participants
n=206 Participants
Birth control methods used in the past
DMPA
42 Participants
n=99 Participants
45 Participants
n=107 Participants
87 Participants
n=206 Participants
Birth control methods used in the past
Barrier
71 Participants
n=99 Participants
71 Participants
n=107 Participants
142 Participants
n=206 Participants
Birth control methods used in the past
Abstinence
4 Participants
n=99 Participants
1 Participants
n=107 Participants
5 Participants
n=206 Participants
Birth control methods used in the past
Withdrawal
14 Participants
n=99 Participants
21 Participants
n=107 Participants
35 Participants
n=206 Participants
Birth control methods used in the past
None
1 Participants
n=99 Participants
3 Participants
n=107 Participants
4 Participants
n=206 Participants
History of STI
13 Participants
n=99 Participants
14 Participants
n=107 Participants
27 Participants
n=206 Participants

PRIMARY outcome

Timeframe: 6 months

Current use of Etonogestrel implant, confirmed via phone by participant palpation, at 6 months post-insertion, with all entire sample used in calculations.

Outcome measures

Outcome measures
Measure
Immediate Nexplanon Insertion
n=73 Participants
An etonogestrel rod will be placed within 15 minutes following the abortion procedure. Immediate Nexplanon Insertion: Patient will have a Nexplanon inserted within 15 minutes of her abortion
Post-op Nexplanon Insertion
n=75 Participants
Participants in the "delayed" placement group will be asked to return to Magee-Womens Hospital for a post-abortion visit 2-4 weeks following the procedure. Participants in the delayed group will be offered a method of contraception to use in the interim between their procedure and their insertion appointment. At this time an etonogestrel rod will be placed in her arm using standard procedure. Post-op Nexplanon Insertion: Place Nexplanon at post operative visit rather than at surgery
Intention-to-treat Analysis of Etonogestrel Implant Use
Using implant at 6 months
40 Participants
19 Participants
Intention-to-treat Analysis of Etonogestrel Implant Use
Implant removed before 6 months
3 Participants
3 Participants

PRIMARY outcome

Timeframe: 6 months

Population: Calculated using only participants who completed the 6-month follow-up.

Current use of Etonogestrel implant, confirmed via phone by participant palpation, at 6 months post-insertion, with only participants who completed the 6-month follow-up used in calculations.

Outcome measures

Outcome measures
Measure
Immediate Nexplanon Insertion
n=43 Participants
An etonogestrel rod will be placed within 15 minutes following the abortion procedure. Immediate Nexplanon Insertion: Patient will have a Nexplanon inserted within 15 minutes of her abortion
Post-op Nexplanon Insertion
n=30 Participants
Participants in the "delayed" placement group will be asked to return to Magee-Womens Hospital for a post-abortion visit 2-4 weeks following the procedure. Participants in the delayed group will be offered a method of contraception to use in the interim between their procedure and their insertion appointment. At this time an etonogestrel rod will be placed in her arm using standard procedure. Post-op Nexplanon Insertion: Place Nexplanon at post operative visit rather than at surgery
Per-protocol Analysis of Etonogestrel Implant Use
Using implant at 6 months
40 Participants
19 Participants
Per-protocol Analysis of Etonogestrel Implant Use
Implant removed before 6 months
3 Participants
3 Participants
Per-protocol Analysis of Etonogestrel Implant Use
Implant never placed
0 Participants
8 Participants

SECONDARY outcome

Timeframe: 6 months

Occurrence of a pregnancy within 6 months after second-trimester abortion.

Outcome measures

Outcome measures
Measure
Immediate Nexplanon Insertion
n=43 Participants
An etonogestrel rod will be placed within 15 minutes following the abortion procedure. Immediate Nexplanon Insertion: Patient will have a Nexplanon inserted within 15 minutes of her abortion
Post-op Nexplanon Insertion
n=30 Participants
Participants in the "delayed" placement group will be asked to return to Magee-Womens Hospital for a post-abortion visit 2-4 weeks following the procedure. Participants in the delayed group will be offered a method of contraception to use in the interim between their procedure and their insertion appointment. At this time an etonogestrel rod will be placed in her arm using standard procedure. Post-op Nexplanon Insertion: Place Nexplanon at post operative visit rather than at surgery
Repeat Pregnancy
Repeat pregnancy within 6 months
1 Participants
1 Participants
Repeat Pregnancy
No repeat pregnancy in 6 months
42 Participants
29 Participants

OTHER_PRE_SPECIFIED outcome

Timeframe: Within 4 weeks of abortion

Whether participants had the implant inserted as part of the study

Outcome measures

Outcome measures
Measure
Immediate Nexplanon Insertion
n=73 Participants
An etonogestrel rod will be placed within 15 minutes following the abortion procedure. Immediate Nexplanon Insertion: Patient will have a Nexplanon inserted within 15 minutes of her abortion
Post-op Nexplanon Insertion
n=75 Participants
Participants in the "delayed" placement group will be asked to return to Magee-Womens Hospital for a post-abortion visit 2-4 weeks following the procedure. Participants in the delayed group will be offered a method of contraception to use in the interim between their procedure and their insertion appointment. At this time an etonogestrel rod will be placed in her arm using standard procedure. Post-op Nexplanon Insertion: Place Nexplanon at post operative visit rather than at surgery
Implant Inserted
73 Participants
32 Participants

OTHER_PRE_SPECIFIED outcome

Timeframe: 6 months

Whether participants completed 6-month phone call follow-up.

Outcome measures

Outcome measures
Measure
Immediate Nexplanon Insertion
n=73 Participants
An etonogestrel rod will be placed within 15 minutes following the abortion procedure. Immediate Nexplanon Insertion: Patient will have a Nexplanon inserted within 15 minutes of her abortion
Post-op Nexplanon Insertion
n=75 Participants
Participants in the "delayed" placement group will be asked to return to Magee-Womens Hospital for a post-abortion visit 2-4 weeks following the procedure. Participants in the delayed group will be offered a method of contraception to use in the interim between their procedure and their insertion appointment. At this time an etonogestrel rod will be placed in her arm using standard procedure. Post-op Nexplanon Insertion: Place Nexplanon at post operative visit rather than at surgery
Completed 6-month Phone Call
43 Participants
30 Participants

Adverse Events

Immediate Nexplanon Insertion

Serious events: 0 serious events
Other events: 2 other events
Deaths: 0 deaths

Post-op Nexplanon Insertion

Serious events: 0 serious events
Other events: 1 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
Immediate Nexplanon Insertion
n=73 participants at risk
An etonogestrel rod will be placed within 15 minutes following the abortion procedure. Immediate Nexplanon Insertion: Patient will have a Nexplanon inserted within 15 minutes of her abortion
Post-op Nexplanon Insertion
n=75 participants at risk
Participants in the "delayed" placement group will be asked to return to Family Planning Associates for a post-abortion visit 2-4 weeks following the procedure. Participants in the delayed group will be offered a method of contraception to use in the interim between their procedure and their insertion appointment. At this time an etonogestrel rod will be placed in her arm using standard procedure. Post-op Nexplanon Insertion: Place Nexplanon at post operative visit rather than at surgery
Gastrointestinal disorders
Nausea and Vomiting
0.00%
0/73 • 2 years
1.3%
1/75 • Number of events 3 • 2 years
Metabolism and nutrition disorders
Rapid weight loss
0.00%
0/73 • 2 years
1.3%
1/75 • Number of events 3 • 2 years
Reproductive system and breast disorders
Post abortal endometritis
1.4%
1/73 • Number of events 1 • 2 years
0.00%
0/75 • 2 years
Reproductive system and breast disorders
Pregnancy
1.4%
1/73 • Number of events 1 • 2 years
0.00%
0/75 • 2 years

Additional Information

Allison A. Cowett, MD MPH

Family Planning Associates Medical Group , Ltd.

Phone: 312-707-8988

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place